Tildrakizumab: the Patient Journey

Those impacted know too well the challenges of living with moderate-to-severe plaque psoriasis. With recent treatment innovations, new biologic drugs like tildrakizumab (Ilumya), an interleukin-23 (IL-23) inhibitor, your symptoms can be successfully controlled and you can regain your quality of life. To start, it is important that you seek medical advice from your dermatologist. Achieving long-term clear skin is possible with the right treatment!

This video contents:

00:00 – IL-23 video series INTRO
00:15 – How psoriasis affects your life?
01:10 – How psoriasis makes you feel?
02:29 – Why did you decide to seek help?
03:35 – What does your treatment involve?
04:34 – Describe your skin before and after treatment.
05:08 – How has your life changed since ILUMYA treatment?
06:04 – Your impression of the outcome of ILUMYA treatment?

Back to First Video

IL-23s: Psoriasis therapy overview

This physician-led video initiative explores community experience with the long-term use and effect of interleukin-23 (IL-23) psoriasis therapies.